Saturday 17 October 2026
Export HLTHQ’s income statement to Excel — free account
Cue Health Inc.
HLTHQ Healthcare Health Information Services
Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
0.00
0.00
NaN
Follow HLTHQ
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 3 | 2 |
P/E ratio |
— | 17.01 | 17.01 | 6.29 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 3.75 | 1.35 | (5.66) |
P/S ratio |
— | 1.78 | 1.78 | 1.15 | 0.65 | 0.50 |
Altman Z″-Score (non-manufacturers) |
— | — | (1.19) | 7.97 | 4.95 | (9.26) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | 21.18 | (3.25) | — |
P/Operating CF |
— | (139.48) | (139.48) | 80.04 | (6.10) | (1.22) |
P/B ratio |
— | 0.00 | 0.00 | 1.00 | 0.55 | 0.14 |
Price to Tangible BV |
— | 0.00 | 0.00 | 1.01 | 0.56 | 0.15 |
EV/Sales |
— | 2.04 | 2.04 | 0.47 | 0.15 | (0.65) |
EV/EBITDA |
— | 5.49 | 5.49 | 1.29 | 0.00 | 0.14 |
EV/Operating CF |
— | 7.85 | 7.85 | (30.46) | (0.66) | 0.33 |
EV/FCF |
— | (5.24) | (5.24) | (2.30) | (0.42) | 0.29 |
Quick Ratio |
— | 3.06 | 0.85 | 3.16 | 3.67 | 1.91 |
Current Ratio |
— | 3.26 | 1.18 | 4.01 | 5.21 | 2.54 |
Net Debt/EBITDA |
— | 0.41 | 3.10 | (1.88) | 1.54 | 0.24 |
Debt/Assets |
0.00% | 0.00% | 2.30% | 0.35% | 0.12% | 0.00% |
Debt/Equity |
— | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.15 | 0.98 | 0.59 | 0.14 |
Operating CF/Net income |
— | 0.63 | (1.96) | (0.29) | 0.58 | 0.37 |
Capex/Depreciation |
— | (0.81) | (12.44) | (3.53) | (1.29) | (0.35) |
Interest Coverage |
— | (136.62) | (120.66) | 19.39 | (318.84) | (340.68) |
| — | 25.83% | 59.36% | 10.94% | (30.24%) | (90.35%) | |
| — | 0.00% | (29.94%) | 5.27% | (23.74%) | (72.21%) | |
ROIC |
— | 0.00% | 0.00% | 41.52% | (38.37%) | (146.40%) |
Return on Tangible Assets |
— | (92.06%) | (36.01%) | 4.86% | (39.67%) | (268.69%) |
Average Days of Receivables |
— | 11.02 | 66.28 | 61.76 | 14.16 | 6.96 |
Research and Development Expense of Revenue |
— | 323.05% | 124.07% | 6.93% | 35.46% | 212.33% |
Selling, General and Administrative Expense of Revenue |
— | 90.37% | 107.39% | 17.56% | 38.41% | 126.79% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.06 |
Share Based Compensation of Revenue |
— | 5.07% | 13.78% | 7.15% | 13.30% | 68.70% |
Graham Net Nets |
— | (0.32) | (0.32) | 0.62 | 0.80 | 0.59 |
Graham Number |
— | 0.00 | 0.00 | 25.33 | 0.00 | 0.00 |
Earnings Yield |
— | 5.88% | 5.88% | 15.89% | (61.50%) | (1,060.87%) |
Free Cash Flow Yield |
— | (21.84%) | (21.84%) | (17.67%) | (55.49%) | (448.24%) |
Revenue per Share |
— | 0.42 | 1.41 | 11.70 | 3.27 | 0.46 |
Operating CF per Share |
— | (0.82) | 5.68 | (0.18) | (0.76) | (0.90) |
Capex per Share |
— | (0.19) | (4.79) | (2.19) | (0.43) | (0.13) |
Free Cash Flow per Share |
— | (1.01) | 0.89 | (2.37) | (1.18) | (1.03) |
Cash per Share |
— | 0.91 | 7.82 | 8.02 | 1.64 | 0.53 |
Shareholders Equity per Share |
— | 0.00 | 4.59 | 13.38 | 3.89 | 1.64 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 4.59 | 13.38 | 3.89 | 1.64 |
Free Cash Flow |
— | (15.94) | 14.51 | (125.17) | (174.95) | (157.61) |
Working Capital |
— | 10.75 | 27.80 | 503.09 | 299.96 | 66.90 |
Capital Expenditures |
— | (2.94) | (78.15) | (115.72) | (63.03) | (19.80) |
Net Current Asset Value |
— | 15.50 | (57.71) | 436.71 | 253.07 | 20.83 |
EV/EBIT |
— | 0.00 | 0.00 | 1.51 | 0.00 | 0.12 |
Capex to Sales |
— | 0.44 | 3.40 | 0.19 | 0.13 | 0.28 |
Price to Operating Income |
— | 0.00 | 0.00 | 3.72 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
— | 0.31 | 0.06 | 0.19 | 0.26 | 0.78 |
Cash ROIC |
— | (73.88%) | 6.91% | (11.04%) | (21.34%) | (47.48%) |
Accounts Receivable Turnover |
— | 3.03 | 10.51 | 11.37 | 7.84 | 7.06 |
Accounts Payable Turnover |
— | 0.00 | 1.20 | 9.06 | 14.88 | 17.11 |
Inventory Turnover |
— | — | 0.24 | 4.42 | 3.87 | 2.64 |
Average Days of Payables |
— | 0.00 | 582.18 | 49.11 | 7.91 | 22.13 |
Days of Inventory on Hand |
— | — | 899.43 | 116.66 | 90.94 | 40.32 |
Average Receivables |
— | 2.18 | 2.18 | 54.38 | 61.67 | 10.05 |
Average Payables |
— | 12.51 | 12.51 | 30.53 | 22.18 | 7.43 |
Average Inventory |
— | — | 62.62 | 62.62 | 85.30 | 48.12 |
Average Assets |
— | 0.00 | 158.16 | 628.19 | 817.32 | 517.18 |
Average Common Equity |
— | (79.77) | (79.77) | 302.68 | 641.62 | 413.37 |
Columns are period end dates